v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities    
Net earnings $ 2,021 $ 1,538
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation 241 214
Amortization of intangible assets 355 354
Asset impairments 1 90
Share-based compensation 141 133
Sale of inventory stepped-up to fair value at acquisition 0 99
Deferred income tax (benefit) expense 74 176
Changes in operating assets and liabilities:    
Accounts receivable 267 257
Inventories (240) (226)
Accounts payable (127) (269)
Accrued expenses and other liabilities (356) (116)
Income taxes (258) (610)
Other, net (277) (279)
Net cash provided by operating activities 1,842 1,361
Investing activities    
Acquisitions, net of cash acquired (459) (4,814)
Purchases of marketable securities (19) (27)
Proceeds/(Purchases) of short-term investments 0 750
Proceeds from sales of marketable securities 23 32
Purchases of property, plant and equipment (368) (306)
Proceeds from the sale of the Spinal Implants business 0 165
Other investing, net (1) (40)
Net cash used in investing activities (824) (4,240)
Financing activities    
Proceeds (payments) on short-term borrowings, net 250 2
Proceeds from issuance of long-term debt 0 2,979
Payments on long-term debt (1,000) (650)
Payments of dividends (674) (641)
Cash paid for taxes from withheld shares (146) (115)
Other financing, net (35) (30)
Net cash provided by (used in) financing activities (1,605) 1,545
Effect of exchange rate changes on cash and cash equivalents (33) 57
Change in cash and cash equivalents (620) (1,277)
Cash and cash equivalents at beginning of period 4,011 3,652
Cash and cash equivalents at end of period $ 3,391 $ 2,375